AN2 Therapeutics, Inc. ($ANTX)
Filing Information
| Accession Number | 0001193125-26-006765 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 8, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
9,251
Total Value
$9,332.36
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer | Common Stock | โ | Jan 5, 2026 | Sale | 3,295 | $1.00 | $3,304.88 | 81,779 | Direct | โ | View Details | |
Chief Development Officer | Common Stock | โ | Jan 6, 2026 | Sale | 5,956 | $1.01 | $6,027.47 | 75,823 | Direct | โ | View Details |